PHAR - Pharming Group N.V. (PHAR) Q4 2024 Earnings Call Transcript
2025-03-13 19:44:30 ET
Pharming Group N.V. (PHAR)
Q4 2024 Earnings Conference Call
March 13, 2025, 8:30 a.m. ET
Company Participants
Fabrice Chouraqui - CEO
Stephen Toor - CCO
Anurag Relan - Chief Medical Officer
Jeroen Wakkerman - CFO
Conference Call Participants
Jeff Jones – Oppenheimer
Ben Jackson – Jefferies
Alistair Campbell - RBC Capital Markets
Joe Pantginis - H.C. Wainwright
Simon Scholes - First Berlin
Presentation
Operator
Good day and thank you for standing by. Welcome to the Pharming Group Fourth Quarter and Full-year 2024 Results Conference Call and Webcast. [Operator Instructions] Please be advised that today's conference is being recorded. I'd now like to hand the conference over to your first speaker today, Fabrice Chouraqui, CEO. Please go ahead, sir.
Fabrice Chouraqui
Thank you very much. Hello, everyone, and welcome to the Pharming’s full-year and Q4 2024 financial results Call. I'm Fabrice Chouraqui, CEO of Pharming, and I'll be joined on this call today by Stephen Toor, our Chief Commercial Officer, Anurag Relan, our Chief Medical Officer, and Jeroen Wakkerman, our Chief Financial Officer.
We'll be making forward-looking statements in this call that are based upon our current insights and plans. As you know, this may differ from future results....
Pharming Group N.V. (PHAR) Q4 2024 Earnings Call Transcript